Norcros Valuation

Q: What is the Fair Price of NXRl when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

NXRl (£2.66) is trading above our estimate of [[fair value]] (£2.31)

Is NXRl undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NXRl when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NXRl (£2.66) is trading above our estimate of fair value (£2.31)

Significantly Below Fair Value: NXRl is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NXRl?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for NXRl. This is calculated by dividing NXRl's market cap by their current preferred multiple.
What is NXRl's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	n/a

NXRl key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.8x
Enterprise Value/EBITDA	5.6x
PEG Ratio	-7.4x

Price to Earnings Ratio vs Peers

How does NXRl's PE Ratio compare to its peers?

The above table shows the PE ratio for NXRl vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	16x
ECEL Eurocell	14.7x	22.3%	UK£186.2m
EPWN Epwin Group	16.4x	15.2%	UK£149.1m
ALU Alumasc Group	12.6x	9.7%	UK£108.2m
JHD James Halstead	20.2x	4.1%	UK£846.1m
NXRl Norcros	8.9x	-1.2%	UK£237.9m

Price-To-Earnings vs Peers: NXRl is good value based on its Price-To-Earnings Ratio (8.9x) compared to the peer average (16x).

Price to Earnings Ratio vs Industry

How does NXRl's PE Ratio compare vs other companies in the European Building Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	15.8%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	15.8%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: NXRl is good value based on its Price-To-Earnings Ratio (8.9x) compared to the European Building industry average (19.7x).

Price to Earnings Ratio vs Fair Ratio

What is NXRl's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NXRl PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	8.9x
Fair PE Ratio	11.2x

Price-To-Earnings vs Fair Ratio: NXRl is good value based on its Price-To-Earnings Ratio (8.9x) compared to the estimated Fair Price-To-Earnings Ratio (11.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NXRl forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	UK£2.66	UK£3.56 +34.0%	20.3%	UK£4.79	UK£2.60	n/a	6
Nov ’25	UK£2.71	UK£3.56 +31.2%	20.3%	UK£4.79	UK£2.60	n/a	6
Oct ’25	UK£2.44	UK£3.56 +45.8%	20.3%	UK£4.79	UK£2.60	n/a	6
Sep ’25	UK£2.22	UK£3.56 +60.2%	20.3%	UK£4.79	UK£2.60	n/a	6
Aug ’25	UK£2.34	UK£3.56 +52.0%	20.3%	UK£4.79	UK£2.60	n/a	6
Jul ’25	UK£2.30	UK£3.44 +49.6%	21.5%	UK£4.79	UK£2.60	n/a	6
Jun ’25	UK£2.19	UK£3.09 +41.1%	18.7%	UK£4.00	UK£2.20	n/a	5
May ’25	UK£1.90	UK£3.11 +63.7%	18.6%	UK£4.00	UK£2.20	n/a	5
Apr ’25	UK£1.85	UK£3.11 +68.1%	18.6%	UK£4.00	UK£2.20	n/a	5
Mar ’25	UK£1.85	UK£3.11 +68.6%	18.6%	UK£4.00	UK£2.20	n/a	5
Feb ’25	UK£1.86	UK£3.08 +65.8%	20.8%	UK£4.00	UK£2.20	n/a	4
Jan ’25	UK£1.92	UK£3.08 +60.6%	20.8%	UK£4.00	UK£2.20	n/a	4
Dec ’24	UK£1.70	UK£3.08 +81.4%	20.8%	UK£4.00	UK£2.20	n/a	4
Nov ’24	UK£1.43	UK£3.21 +125.4%	20.5%	UK£4.00	UK£2.20	UK£2.71	4
Oct ’24	n/a	UK£3.21 0%	20.5%	UK£4.00	UK£2.20	UK£2.44	4
Sep ’24	UK£1.50	UK£3.21 +114.2%	20.5%	UK£4.00	UK£2.20	UK£2.22	4
Aug ’24	UK£1.65	UK£3.21 +94.7%	20.5%	UK£4.00	UK£2.20	UK£2.34	4
Jul ’24	UK£1.71	UK£2.95 +72.5%	18.6%	UK£3.50	UK£2.20	UK£2.30	3
Jun ’24	UK£1.75	UK£3.02 +72.4%	15.2%	UK£3.50	UK£2.40	UK£2.19	3
May ’24	UK£1.84	UK£3.02 +64.4%	15.2%	UK£3.50	UK£2.40	UK£1.90	3
Apr ’24	UK£1.85	UK£3.18 +72.1%	17.5%	UK£3.65	UK£2.40	UK£1.85	3
Mar ’24	UK£1.99	UK£3.18 +60.0%	17.5%	UK£3.65	UK£2.40	UK£1.85	3
Feb ’24	UK£2.08	UK£3.18 +53.0%	17.5%	UK£3.65	UK£2.40	UK£1.86	3
Jan ’24	n/a	UK£3.18 0%	17.5%	UK£3.65	UK£2.40	UK£1.92	3
Dec ’23	UK£1.88	UK£3.18 +69.1%	17.5%	UK£3.65	UK£2.40	UK£1.70	3
Nov ’23	UK£1.80	UK£3.55 +97.8%	23.1%	UK£4.50	UK£2.50	UK£1.43	3

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.